Phillip Selman

SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.

A. Dey, D. V. Vander Griend, Steven Kregel, 2023, Cancer letters.

Selective Glucocorticoid Receptor Modulators (SGRMs) Delay Castrate-Resistant Prostate Cancer Growth

S. Conzen, Jacob Kach, W. Chan, 2017, Molecular Cancer Therapeutics.

Characterizing Cyclin J By Identifying Conserved Protein-Protein Interactions

P. Selman, Phillip Selman, 2013 .

Accelerator-Based Production of Scandium Radioisotopes for Applications in Prostate Cancer: Toward Building a Pipeline for Rapid Development of Novel Theranostics

R. Weichselbaum, C. Kao, Hannah J. Zhang, 2023, Molecules.